Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: Relationship to cardiovascular risk and treatment

被引:0
|
作者
Tayebjee, MH [1 ]
Nadar, SK [1 ]
Blann, AD [1 ]
Beevers, DG [1 ]
MacFadyen, RJ [1 ]
Lip, GY [1 ]
机构
[1] City Hosp, Univ Dept Med, Birmingham, W Midlands, England
关键词
hypertension; matrix metalloproteinase; cardiovascular risk;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
OR53
引用
收藏
页码:23A / 23A
页数:1
相关论文
共 50 条
  • [41] MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN NASAL SECRETIONS OF CHILDREN WITH AND WITHOUT ALLERGIC RHINITIS
    Basheeth, N.
    Fenton, J. E.
    De, S.
    Carter, S. D.
    Clarke, R. W.
    Jones, A. S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 : S40 - S40
  • [42] Secretion of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Meningiomas Detected by Cell Immunoblot Analysis
    T. Mizoue
    H. Kawamoto
    K. Arita
    A. Tominaga
    K. Kurisu
    Acta Neurochirurgica, 1999, 141 : 481 - 486
  • [43] The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients
    Eisner, Logan
    Vambutas, Andrea
    Pathak, Shresh
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (08): : 354 - 361
  • [44] Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis
    Mizoue, T
    Kawamoto, H
    Arita, K
    Tominaga, A
    Kurisu, K
    ACTA NEUROCHIRURGICA, 1999, 141 (05) : 481 - 486
  • [45] SIGNIFICANCE OF SERUM MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN CHRONIC HEPATITIS C PATIENTS
    Badra, Gamal
    Lotfy, Mahmoud
    El-Refaie, Amany
    Obada, Moanis
    Abdelmonem, Elhamy
    Kandeel, Samia
    Fathy, Amr
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2010, 57 (01) : 29 - 42
  • [46] Modulation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in RAW264.7 cells by irradiation
    Zhou, Y.
    Xia, L.
    Zhou, Y. J.
    He, Z. S.
    Ouyang, W.
    Z, H.
    Zhou, Y. F.
    Xie, C. H.
    MOLECULAR MEDICINE REPORTS, 2010, 3 (05) : 809 - 813
  • [47] Elevated Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in the Acute Phase of Kawasaki Syndrome
    Pong Kian Chua
    Marian E Melish
    Qigui Yu
    Kara S Yamamoto
    Richard Yanagihara
    Vivek R Nerurkar
    Pediatric Research, 2003, 53 : 170 - 170
  • [48] Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy
    Li-Saw-Hee, FL
    Edmunds, E
    Blann, AD
    Beevers, DG
    Lip, GYH
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (01) : 43 - 47
  • [49] Patients with acute coronary syndromes have increased levels of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1
    Manginas, A
    Bel, E
    Pilatis, N
    Chaidaroglou, A
    Degiannis, D
    Koniavitou, E
    Gokkinos, DV
    CIRCULATION, 2002, 106 (19) : 695 - 695
  • [50] Serum matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 and left venricle performance in patients with aortic stenosis
    Goncharova, N.
    Moiseeva, O.
    Aleshina, G.
    Shlykhto, E.
    CIRCULATION, 2008, 118 (12) : E248 - E248